These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18778944)

  • 21. Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation.
    Saberi MR; Vinh TK; Yee SW; Griffiths BJ; Evans PJ; Simons C
    J Med Chem; 2006 Feb; 49(3):1016-22. PubMed ID: 16451067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of Rhus verniciflua Stokes extract on human aromatase activity; butin is its major bioactive component.
    Park MH; Kim IS; Kim SA; Na CS; Hong CY; Dong MS; Yoo HH
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1730-3. PubMed ID: 24630560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline.
    Kellis JT; Vickery LE
    Endocrinology; 1984 Jun; 114(6):2128-37. PubMed ID: 6723577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of hop (Humulus lupulus L.) flavonoids on aromatase (estrogen synthase) activity.
    Monteiro R; Becker H; Azevedo I; Calhau C
    J Agric Food Chem; 2006 Apr; 54(8):2938-43. PubMed ID: 16608212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of an Indonesian herbal constituents database and its use in Random Forest modelling in a search for inhibitors of aldose reductase.
    Naeem S; Hylands P; Barlow D
    Bioorg Med Chem; 2012 Feb; 20(3):1251-8. PubMed ID: 22261024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular modeling evaluation of non-steroidal aromatase inhibitors.
    Narayana BL; Pran Kishore D; Balakumar C; Rao KV; Kaur R; Rao AR; Murthy JN; Ravikumar M
    Chem Biol Drug Des; 2012 May; 79(5):674-82. PubMed ID: 22129073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]-1H-indoles: potent and selective aromatase inhibitors.
    Lézé MP; Le Borgne M; Pinson P; Palusczak A; Duflos M; Le Baut G; Hartmann RW
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1134-7. PubMed ID: 16380254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effects of flavonoids on xanthine oxidase.
    Chang WS; Lee YJ; Lu FJ; Chiang HC
    Anticancer Res; 1993; 13(6A):2165-70. PubMed ID: 8297130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory activities of prenylated flavonoids from Sophora flavescens against aldose reductase and generation of advanced glycation endproducts.
    Jung HA; Yoon NY; Kang SS; Kim YS; Choi JS
    J Pharm Pharmacol; 2008 Sep; 60(9):1227-36. PubMed ID: 18718128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Galangin, a flavonol derived from Rhizoma Alpiniae Officinarum, inhibits acetylcholinesterase activity in vitro.
    Guo AJ; Xie HQ; Choi RC; Zheng KY; Bi CW; Xu SL; Dong TT; Tsim KW
    Chem Biol Interact; 2010 Sep; 187(1-3):246-8. PubMed ID: 20452337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating flavonoids as potential aromatase inhibitors for breast cancer treatment: In vitro studies and in silico predictions.
    Seo JI; Yu JS; Zhang Y; Yoo HH
    Chem Biol Interact; 2024 Apr; 392():110927. PubMed ID: 38403145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-steroidal aromatase inhibitors based on a biphenyl scaffold: synthesis, in vitro SAR, and molecular modelling.
    Jackson T; Woo LW; Trusselle MN; Purohit A; Reed MJ; Potter BV
    ChemMedChem; 2008 Apr; 3(4):603-18. PubMed ID: 18236493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroidal pyrazolines evaluated as aromatase and quinone reductase-2 inhibitors for chemoprevention of cancer.
    Abdalla MM; Al-Omar MA; Bhat MA; Amr AG; Al-Mohizea AM
    Int J Biol Macromol; 2012 May; 50(4):1127-32. PubMed ID: 22361454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and aromatase inhibiting activity of aminoglutethimide analogs.
    Aboul-Enein HY
    Drug Des Deliv; 1988 Feb; 2(3):221-6. PubMed ID: 3255316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of bisphenol A-related diphenylalkanes on vitellogenin production in male carp (Cyprinus carpio) hepatocytes and aromatase (CYP19) activity in human H295R adrenocortical carcinoma cells.
    Letcher RJ; Sanderson JT; Bokkers A; Giesy JP; van den Berg M
    Toxicol Appl Pharmacol; 2005 Dec; 209(2):95-104. PubMed ID: 15907334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of luteolin on estrogen biosynthesis in human ovarian granulosa cells by suppression of aromatase (CYP19).
    Lu DF; Yang LJ; Wang F; Zhang GL
    J Agric Food Chem; 2012 Aug; 60(34):8411-8. PubMed ID: 22838964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic isoflavones and doping: A novel class of aromatase inhibitors?
    Iannone M; Botrè F; Cardillo N; de la Torre X
    Drug Test Anal; 2019 Feb; 11(2):208-214. PubMed ID: 30118172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aromatase inhibitors and antiepileptic drugs: a computational systems biology analysis.
    Muftuoglu Y; Mustata G
    Reprod Biol Endocrinol; 2011 Jun; 9():92. PubMed ID: 21693043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical constituents of the stem bark of Morus cathayana.
    Ni G; Zhang QJ; Wang YH; Chen RY; Zheng ZF; Yu DQ
    J Asian Nat Prod Res; 2010 Jun; 12(6):505-15. PubMed ID: 20552491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents.
    Lu WJ; Xu C; Pei Z; Mayhoub AS; Cushman M; Flockhart DA
    Breast Cancer Res Treat; 2012 May; 133(1):99-109. PubMed ID: 21814747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.